Peer Reviewed Cancer
FY24 Convergent Science Cancer Consortium Award
The list of Fiscal Year 2024 Peer Reviewed Cancer Research Program Convergent Science Cancer Consortium Award applications recommended for funding is for informational purposes only. Identification on the list of applications recommended for funding is not intended to either confer a right to funding nor does it guarantee funding. The award of federal funds to support any of these applications is contingent upon successful negotiations and applicable federal policy.
| Institution | Principal Investigator |
|---|---|
| The University of Texas MD Anderson Cancer Center | Christopher Flowers |
| University of Houston | Navin Varadarajan |
| Vanderbilt University Medical Center | Jeffrey Rathmell |
Last updated Wednesday, September 24, 2025